OBJECTIVE	Ceftaroline fosamil , a novel parenteral cephalosporin with excellent in vitro activity against Gram-positive pathogens , including MRSA , and many Gram-negative pathogens , was evaluated as therapy for cSSSIs in a large multicentre study .\